DE60021350D1 - Mmp-hemmer bei bindegewebserweichung - Google Patents

Mmp-hemmer bei bindegewebserweichung

Info

Publication number
DE60021350D1
DE60021350D1 DE60021350T DE60021350T DE60021350D1 DE 60021350 D1 DE60021350 D1 DE 60021350D1 DE 60021350 T DE60021350 T DE 60021350T DE 60021350 T DE60021350 T DE 60021350T DE 60021350 D1 DE60021350 D1 DE 60021350D1
Authority
DE
Germany
Prior art keywords
hemmer
mmp
binding web
substance
web substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60021350T
Other languages
English (en)
Other versions
DE60021350T2 (de
Inventor
Mark William James Ferguson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of DE60021350D1 publication Critical patent/DE60021350D1/de
Publication of DE60021350T2 publication Critical patent/DE60021350T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Package Frames And Binding Bands (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
DE60021350T 1999-02-18 2000-02-14 Mmp-hemmer bei bindegewebserweichung Expired - Lifetime DE60021350T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9903598.2A GB9903598D0 (en) 1999-02-18 1999-02-18 Connective tissue healing
GB9903598 1999-02-18
PCT/GB2000/000474 WO2000048617A2 (en) 1999-02-18 2000-02-14 Connective tissue softening

Publications (2)

Publication Number Publication Date
DE60021350D1 true DE60021350D1 (de) 2005-08-25
DE60021350T2 DE60021350T2 (de) 2006-04-27

Family

ID=10847938

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60021350T Expired - Lifetime DE60021350T2 (de) 1999-02-18 2000-02-14 Mmp-hemmer bei bindegewebserweichung

Country Status (13)

Country Link
US (1) US6455569B1 (de)
EP (1) EP1152757B1 (de)
JP (1) JP2002537268A (de)
AT (1) ATE299703T1 (de)
AU (1) AU772470B2 (de)
CA (1) CA2362279C (de)
DE (1) DE60021350T2 (de)
DK (1) DK1152757T3 (de)
ES (1) ES2244410T3 (de)
GB (1) GB9903598D0 (de)
HK (1) HK1037960A1 (de)
PT (1) PT1152757E (de)
WO (1) WO2000048617A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436629B1 (en) * 2000-10-27 2002-08-20 The Regents Of The University Of California Modulating angiogenesis
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
US20070259030A1 (en) * 2006-05-05 2007-11-08 Drapeau Susan J Methods, systems and reagents for tendon and ligament therapy
US8247384B2 (en) 2006-11-15 2012-08-21 Coda Therapeutics, Inc. Methods and compositions for wound healing
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
CA2710386A1 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Improved medical devices
US20110217313A1 (en) * 2007-12-21 2011-09-08 Becker David L Treatment of orthopedic conditions
CA2710388A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides for the treatment of abnormal or excessive scars
CN114010788A (zh) 2014-08-22 2022-02-08 奥克兰联合服务有限公司 通道调节剂
WO2022128057A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for prevention and treatment of collagen degradation in human connecting tissue

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827305D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
US5239078A (en) * 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5318964A (en) 1992-06-11 1994-06-07 Hoffmann-La Roche Inc. Hydroxamic derivatives and pharmaceutical compositions
US5310759A (en) 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
JPH08511509A (ja) * 1993-04-07 1996-12-03 グリコメド・インコーポレイテッド 合成マトリックスメタロプロテアーゼ阻害剤およびその用途
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
DE19542189A1 (de) 1995-11-13 1997-05-15 Hoechst Ag Cyclische N-substituierte alpha-Iminohydroxamsäuren
PL186869B1 (pl) * 1995-11-13 2004-03-31 Hoechst Ag Nowe heterocykliczne N-podstawione pochodne kwasów alfa-iminohydroksamowych i karboksylowych, sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie
GB9714936D0 (en) 1997-07-17 1997-09-17 Smith & Nephew Cell culture products

Also Published As

Publication number Publication date
AU2557100A (en) 2000-09-04
GB9903598D0 (en) 1999-04-07
HK1037960A1 (en) 2002-03-01
WO2000048617A2 (en) 2000-08-24
PT1152757E (pt) 2005-09-30
DE60021350T2 (de) 2006-04-27
US6455569B1 (en) 2002-09-24
AU772470B2 (en) 2004-04-29
ES2244410T3 (es) 2005-12-16
ATE299703T1 (de) 2005-08-15
CA2362279A1 (en) 2000-08-24
DK1152757T3 (da) 2005-10-31
JP2002537268A (ja) 2002-11-05
EP1152757A2 (de) 2001-11-14
EP1152757B1 (de) 2005-07-20
CA2362279C (en) 2010-05-25
WO2000048617A3 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
DK0987998T3 (da) Decellulering af væv
DE60013859D1 (de) Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis
BR0014078A (pt) Inibidores de fator xa
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE60327800D1 (de) System zur behandlung von fettleibigkeit
BR9916484A (pt) Combinações de inibidores do transporte de ácido biliar ileal e de agentes sequestrantes de ácido biliar em indicações cardiovasculares
WO2002010348A3 (en) Tissue implant for cartilage repair
DE60117977D1 (de) Vorrichtungen zur behandlung von harninkontinenz
ATE413386T1 (de) Ppar-gamma modulatoren
BR0107942A (pt) Polìmeros de proteìna de liberação lenta
ATE234812T1 (de) Integrin antagonisten
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
DE60021350D1 (de) Mmp-hemmer bei bindegewebserweichung
DE60014928D1 (de) Retinoide zur behandlung von emphysem
DE69935853D1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
PT1146897E (pt) Utilizacao de um factor de actividade inibidora de melanomas (mia) para reparacao de cartilagem e de osso
DK0955515T3 (da) Væv, især stikbeskyttende væv
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
DK0818973T3 (da) Bionedbrydelig indretning
BR0013416A (pt) Droga, uso de uma droga selecionada do grupo que consiste de pelo menos um bisfosfonato, e, método para tratamento de um osso fraturado
DE60140864D1 (de) Therapeutische zusammenfassungen und verfahren zur modulierung von v3, eine isoform von versican
DE60016803D1 (de) Heilmittel und/oder prophylactische mittel zur behandlung von nervensystem-störungen
PT841937E (pt) Utilizacao de betaglicano para reduzir a formacao de cicatrizes
BR0108172B1 (pt) composição para cuidado com tecidos, método para tratamento de tecidos, e, uso de um polìmero anfotérico capaz de auto-reticular e/ou de reagir com celulose.
ATE258064T1 (de) Verwendung von antileukoprotease zur behandlung von endometriose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition